IL Chicago의 백혈병 임상 시험
백혈병 관련 연구 19개가 Chicago 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
피험자 모집 중3상
- Northwestern, Chicago
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
피험자 모집 중2상
- Ann and Robert H Lurie Childs Hosp, Chicago
Mosaic Trial for Stem Cell Transplant Recipients
피험자 모집 중
- Northwestern University Feinberg School of Medicine, Chicago
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
피험자 모집 중관찰 연구
- Lurie Children's Hospital-Chicago, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care
피험자 모집 중
- University of Chicago Comprehensive Cancer Center, Chicago
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
피험자 모집 중1/2상
- Research Site, Chicago
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
피험자 모집 중1/2상
- The University of Chicago Medical Center, Chicago
Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable (IGHV)
피험자 모집 중3상
- Research Site, Chicago
Study of Allo-QuadCAR01-T, an Allogeneic CAR-T Targeting CD19/CD20, in Patients With Relapsed or Refractory B-Cell Malignancies
피험자 모집 중1/2상
- University of Chicago, Chicago
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
피험자 모집 중1상
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
피험자 모집 중2상
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)
피험자 모집 중2상
- University of Chicago Medical Center, Chicago
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
피험자 모집 중관찰 연구
- Lurie Children's Hospital-Chicago, Chicago
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
피험자 모집 중1/2상
- University of Illinois at Chicago Cancer Center, Chicago
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
피험자 모집 중1상
- Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago
Spiritual Care Intervention in Adult Patients Diagnosed With Acute Leukemia
피험자 모집 중
- UChicago Medicine Comprehensive Cancer Center, Chicago
CApivasertib, Venetoclax And Low-intensity chemotheRapY for Adults With ALL/LBL
피험자 모집 중1/2상
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Chicago
A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome
피험자 모집 중1상
- Northwestern Medicine - Northwestern Memorial Hospital Galter Pavilion, Chicago
다른 도시의 백혈병 시험
- Houston, TX연구 31개
- Boston, MA연구 27개
- New York City, NY연구 21개
- Los Angeles, CA연구 17개
- Durham, NC연구 14개
- Baldwin Park, CA연구 14개
- Nashville, TN연구 13개
- Columbus, OH연구 13개
- Philadelphia, PA연구 13개
- Atlanta, GA연구 12개
- Milwaukee, WI연구 12개
- Seattle, WA연구 12개
Chicago의 다른 연구
- 유방암연구 59개
- 비소세포폐암연구 59개
- 암 (전체)연구 51개
- 전립선암연구 45개
- 폐암연구 43개
- 전이성 암연구 42개
- 비만연구 40개
- 난소암연구 36개
- 대장직장암연구 32개
- 뇌졸중연구 31개
- 두경부 편평세포암연구 29개
- 과체중연구 29개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.